According to MindBio Therapeutics latest financial reports the total debt is $1.76M, an decrease of -37.36% to 2022. At the end of 2022 company had $2.81M total debt. This figure represents the debts and financial obligations that MindBio Therapeutics combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $1.76M | -37.36% |
2022 | $2.81M | - |